Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19

Y Ouyang, J Yin, W Wang, H Shi, Y Shi… - Clinical infectious …, 2020 - academic.oup.com
Background The World Health Organization characterizes novel coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-…

[HTML][HTML] High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients

…, B Su, L Pang, L Qiao, Y Feng, Y Ouyang… - Cellular & molecular …, 2020 - nature.com
The outbreak of coronavirus disease 2019 (COVID-19) caused by the new virus SARS-CoV-2
has been announced as a public health emergency of international concern. 1-3 The …

[HTML][HTML] The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia

H Shi, W Wang, J Yin, Y Ouyang, L Pang, Y Feng… - Cell death & …, 2020 - nature.com
Although most patients with COVID-19 pneumonia have a good prognosis, some patients
develop to severe or critical illness, and the mortality of critical cases is up to 61.5%. However, …

[HTML][HTML] Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in …

…, Y Shen, P Yang, Y Shi, R Jin, D Liu, Y Ouyang… - Cell Death & …, 2022 - nature.com
Tumor heterogeneity has been associated with immunotherapy and targeted drug resistance
in hepatocellular carcinoma (HCC). However, communications between tumor and …

Etiology and epidemiology of viral diarrhea in children under the age of five hospitalized in Tianjin, China

Y Ouyang, H Ma, M Jin, X Wang, J Wang, L Xu, S Lin… - Archives of …, 2012 - Springer
Viral diarrhea is a great threat to children’s health in developing countries. We conducted a
prospective surveillance study of acute diarrhea of young children at Tianjin Children’s …

[HTML][HTML] CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma

K Liu, M Hao, Y Ouyang, J Zheng, D Chen - Scientific reports, 2017 - nature.com
The role of cancer stem cells (CSCs) in inducing the recurrence of hepatocellular carcinoma
(HCC) after radiofrequency ablation (RFA) remains unclear. Here, we found that a dramatic …

[HTML][HTML] Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009–2016: a retrospective study

X Guo, J Wu, F Wei, Y Ouyang, Q Li, K Liu… - International journal of …, 2018 - Elsevier
Nucleos(t)ide analogues (NAs) are widely used in anti-hepatitis B virus (anti-HBV) therapy
for effective inhibition of HBV replication. However, HBV resistance to NAs has emerged, …

[HTML][HTML] Longitudinal profiling of antibody response in patients with COVID-19 in a tertiary care hospital in Beijing, China

X Feng, J Yin, J Zhang, Y Hu, Y Ouyang… - Frontiers in …, 2021 - frontiersin.org
The novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
caused a global pandemic of the coronavirus disease 2019 (COVID-19), which elicits a …

Activation of EGFR‐KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma

…, X Zhang, W Wang, X Guo, Y Ouyang… - Molecular …, 2019 - Wiley Online Library
Sorafenib is the standard first‐line systemic chemotherapeutic drugs for advanced
hepatocellular carcinoma (HCC), but acquired resistance to sorafenib is frequently observed in …

Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl) methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors …

…, L Zhang, K Qiao, L Li, C Liu, Y Ouyang… - Journal of medicinal …, 2012 - ACS Publications
Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside
reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better …